Disease | osteoporosis |
Phenotype | C0021390|inflammatory bowel disease |
Sentences | 10 |
PubMedID- 22626800 | Metabolic bone disease, including osteomalacia, osteopenia, and osteoporosis, is common in patients with inflammatory bowel disease (ibd) and has been considered to be an extraintestinal manifestation. |
PubMedID- 25472555 | Risks and predictors of osteoporosis in patients with inflammatory bowel diseases in an asian population: a nationwide population-based cohort study. |
PubMedID- 20845083 | Associations among pathologies included inflammatory bowel disease with osteoporosis and dental calculus/periodontitis with atherosclerosis and amyloidosis. |
PubMedID- 24714255 | Background: a high prevalence of osteopenia and osteoporosis is observed in patients with inflammatory bowel disease (ibd). |
PubMedID- 23944617 | The prevalence and risk factors for osteoporosis in patients with inflammatory bowel disease. |
PubMedID- 21664725 | Objectives: to evaluate the prevalence of osteopenia and osteoporosis in patients with inflammatory bowel disease (ibd) and to study the factors involved in their pathogenesis. |
PubMedID- 24714153 | Management algorithm of osteoporosis in inflammatory bowel disease (ibd) [adapted from reference 10]. |
PubMedID- 23691340 | We examined current osteoporosis prevention practices in patients with inflammatory bowel disease (ibd) on chronic steroid using the 2003 american gastroenterological association guidelines as standard of care. |
PubMedID- 23333038 | Health care for osteoporosis in inflammatory bowel disease: unmet needs in care of male patients. |
PubMedID- 24419292 | Risk factors and management of osteoporosis in inflammatory bowel disease. |
Page: 1